TrialJournal of intensive care medicine2022

High- Versus Low-Dose Dexamethasone for the Treatment of COVID-19-Related Acute Respiratory Distress Syndrome: A Multicenter, Randomized Open-Label Clinical Trial.

Luis Patricio Maskin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.